Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

NKTRNKTR
5 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in Nektar Therapeutics

GOLDMAN SACHS GROUP INC holds 228,490 shares of NKTR (Nektar Therapeutics), worth $16M as of 2026-Q2. The position was increased (+80.0% shares). NKTR represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$16M

Current Shares

228,490

Total Value Change

+$14.3M

Total Shares Change

+166,040

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
228,490
+80.0%
$16M0.0%$69.81
43
2026-Q1
Decreased
126,942
-14.1%
$9.1M0.0%$68.11
0
2025-Q4
Increased
147,793
+91.8%
$6.2M0.0%$41.90
43
2025-Q3
Increased
77,055
+23.4%
$4.4M0.0%$58.92
33
2025-Q2
New
62,450
-
$1.6M0.0%$25.76
35

Other major holders of NKTR: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used